ArticleJournal of clinical medicine2025

Does the Timing of Antagonist Treatment Influence Cycle Outcomes in Unexpected Low Responders of POSEIDON Class 1 and 2?

Nina Medić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.